Results

Total Results: 1,246 records

Showing results for "hepatitis c".
Users also searched for: hepatitis c

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_surveillance.pdf
    March 01, 2013 - ...................................................................................... 19 Appendix C. … Appendix C shows the questionnaire matrix used. 2.4 Check for qualitative and quantitative signals … Campbell L, Chen C, Bhagat SS, et al. … 16 Appendices Appendix A: Search Methodology Appendix B: Evidence Tables Appendix C: … No increased incidence of malignancy, TB reactivation or hepatitis was found.
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_surveillance.pdf
    March 01, 2013 - ...................................................................................... 19 Appendix C. … Appendix C shows the questionnaire matrix used. 2.4 Check for qualitative and quantitative signals … Campbell L, Chen C, Bhagat SS, et al. … 16 Appendices Appendix A: Search Methodology Appendix B: Evidence Tables Appendix C: … No increased incidence of malignancy, TB reactivation or hepatitis was found.
  3. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary44/sexually-transmitted-infections-behavioral-counseling-2008
    October 15, 2008 - Exclusion Criteria Clinical conditions Sexual transmission of bacteria or virus (e.g., HIV, hepatitis … B and C, herpes simplex virus, human papillomavirus, chlamydia, gonorrhea, syphilis, and trichomonas … [PMID: 15249566] Bolu OO, Lindsey C, Kamb ML, Kent C, Zenilman J, Douglas JM, et al. … [PMID: 11940275] Proude EM, D'Este C, Ward JE. … [PMID: 9722807] Herbst JH, Beeker C, Mathew A, McNally T, Passin WF, Kay LS, et al.
  4. www.ahrq.gov/patient-safety/reports/advances-new-directions/index.html
    July 01, 2022 - Risk Assessment Risk-Based Patient Safety Metrics (   PDF , 614 KB ) Matthew C. … Creating Safety in the Testing Process in Primary Care Offices (   PDF , 414 KB ) Nancy C.
  5. www.ahrq.gov/sites/default/files/wysiwyg/research/findings/evidence-based-reports/nutrtp2.pdf
    March 01, 2009 - systematic reviews into processes associated with the derivation of nutrient intake reference values; c) … Vitamin C, vitamin E, selenium, and carotenoids. National Academy of Science; 2000. … (16) Counsell C. … (20) Kjaergard LL, Villumsen J, Gluud C. … (23) Balk EM, Bonis PA, Moskowitz H, Schmid CH, Ioannidis JP, Wang C et al.
  6. hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2019.jsp
    January 01, 2019 - STATE-SPECIFIC RESTRICTIONS Table C.1. … Table C.1. … Mycoses 10,755 27.56 28.10 2.0 5: HIV infection 7,495 26.99 27.66 2.5 6: Hepatitis … including parasitic 4,117 13.46 14.09 4.7 9: Sexually transmitted infections (not HIV or hepatitis … Andrews R, Kassed C, Nagamine M.
  7. hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2020.jsp
    January 01, 2020 - STATE-SPECIFIC RESTRICTIONS Table C.1. … Table C.1. … Mycoses 10,755 27.56 28.10 2.0 5: HIV infection 7,495 26.99 27.66 2.5 6: Hepatitis … including parasitic 4,117 13.46 14.09 4.7 9: Sexually transmitted infections (not HIV or hepatitis … Andrews R, Kassed C, Nagamine M.
  8. www.uspreventiveservicestaskforce.org/uspstf/recommendation/syphilis-infection-in-pregnancy-screening-2009
    May 15, 2009 - screening for other sexually transmitted diseases in pregnancy, including gonorrhea, chlamydial infection, hepatitis … [PMID: 15306757] Wolff T, Shelton E, Sessions C, Miller T.
  9. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/unhealthy-alcohol-use-in-adolescents-and-adults-screening-and-behavioral-counseling-interventions
    October 20, 2016 - for adolescents) Alcohol Use Disorders Identification Test (AUDIT), its abbreviated version (AUDIT-C) … health symptoms/disorders; alcohol-related liver problems, including fatty liver disease, alcoholic hepatitis
  10. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan18/drug-use-illicit-primary-care-interventions-for-children-and-adolescents-march-2014
    May 15, 2013 - including, but not limited to: mental health disorders, sexually transmitted infection/HIV transmission, hepatitis … B or C transmission, unintended pregnancies/pregnancy complications, respiratory infections, cardiovascular
  11. integrationacademy.ahrq.gov/products/playbooks/opioid-use-disorder/implement-mat-for-oud/screening-and-diagnosis
    January 01, 2018 - of opioid use disorder; Other relevant medical conditions (i.e., pregnancy testing, liver function, hepatitis … B and C testing, HIV testing); and Other relevant psychiatric disorders, including depression and specifically
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
    March 14, 2013 - ...................................................................................... 19 Appendix C. … Gaujoux-Viala C, Giampietro C, Gaujoux T, et al. Scleritis: a paradoxical effect of etanercept? … Sandborg C, Mellins ED. A new era in the treatment of systemic juvenile idiopathic arthritis. … C-reactive protein and ferritin normalized within this interval in >80%. … AE’s included bacterial infection in 2 patients and hepatitis in 1 Key Question 2: In children with
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
    March 14, 2013 - ...................................................................................... 19 Appendix C. … Gaujoux-Viala C, Giampietro C, Gaujoux T, et al. Scleritis: a paradoxical effect of etanercept? … Sandborg C, Mellins ED. A new era in the treatment of systemic juvenile idiopathic arthritis. … C-reactive protein and ferritin normalized within this interval in >80%. … AE’s included bacterial infection in 2 patients and hepatitis in 1 Key Question 2: In children with
  14. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-228-fullreport.pdf
    February 01, 2018 - Measure Number 0228 1.C. … percent) than costs for treating other conditions between 1997 and 2005 (Rivers, Ahrens, 2008). 3.C. … c. Care Setting – other – please specify: Yes; emergency department. d. … contain questions related to the special health care needs of individuals using the ED. 15 7.C. … Not applicable. 11.C.
  15. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary38/obesity-in-adults-screening-and-management-2012
    October 15, 2011 - Egger M, Davey Smith G, Schneider M, Minder C. … Jeffery RW, Wing RR, Thorson C, Burton LR, Raether C, Harvey J, et al. … Berne C; Orlistat Swedish Type 2 Diabetes Study Group. … Hauptman J, Lucas C, Boldrin MN, Collins H, Segal KR. … Kirk EP, Jacobsen DJ, Gibson C, Hill JO, Donnelly JE.
  16. hcup-us.ahrq.gov/reports/statbriefs/sb244-Opioid-Inpatient-Stays-ED-Visits-Older-Adults.pdf
    February 01, 2018 - Weiss, Ph.D., Kevin C. Heslin, Ph.D., Marguerite L. … + overall 65–74 75–84 85+ 65+ overall 65+ overall 65–74 75–84 85+ 65+ overall Pe rc en ta ge C … 127 Asthma CCS 128 Chronic kidney disease CCS 156, 158 Human immunodeficiency virus (HIV) CCS 5 Hepatitis … u=https-3A__claritas360.claritas.com_mybestsegments_&d=DwMFAg&c=jf_iaSHvJObTbx-siA1ZOg&r=2qQwVBn6hVQgR7RNjEA4Tc2Yt-lUl674IM-sBUsuioI … Weiss, Ph.D., Kevin C. Heslin, Ph.D., Marguerite L.
  17. JAMA (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/2DGd8AvVMTJwP3ttrPcnLL
    February 25, 2020 - Vital Hepatitis, STD, and TB. Trends in the prevalence of tobacco use: national YRBS: 1991-2017. … Selph S, Patnode C, Bailey S, et al Primary Care Relevant Interventions for Tobacco and Nicotine Use … Selph S, Patnode C, Bailey SR, Pappas M, Stoner R, Chou R. … Hiemstra M, Ringlever L, Otten R, van Schayck OC, Jackson C, Engels RC. … Jackson C, Dickinson D.
  18. www.uspreventiveservicestaskforce.org/uspstf/recommendation/drug-abuse-screening-1996
    January 01, 1996 - complications from injecting contaminated materials (e.g., human immunodeficiency virus [HIV] infection, hepatitis … Colmorgen GHC, Johnson C, Zazzarino MA, et al. … Chasnoff IJ, Griffith DR, Freier C, Murray J. … Wickizer T, Maynard C, Atherly A, et al. … Power R, Hartnoll R, Chalmers C.
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_disposition-comments.pdf
    January 15, 2016 - Research Review Citation: Chinnadurai S, Snyder K, Sathe N, Fonnesbeck C, Morad A, Likis FE, Surawicz … T, Ness G, Ficzere C, McPheeters ML. … Peer reviewer #1 Methods Fig C- Final Health Outcomes: is there a causation for problems with thyroid … Timolol – 64% clearance c. intralesionalTriamcinolone – 54% d.
  20. cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_USPSTF%20Statin%20Use%20for%20the%20Primary%20Prevention%20of%20CVD%20in%20Adults_Final.docx
    October 01, 2017 - Patient is likely to have adverse reactions to statins. c. … abnormal blood cholesterol, represented HDL-C < 40 mg/dL or LDL-C > 130 mg/dL Grade B and C "Diabetes … " Type 1 and Type 2 Diabetes Grade B and C "Hypertension" high blood pressure Grade B and C " … the work group, not all liver conditions clearly exclude a recommendation for statin therapy (e.g., Hepatitis … B and C).

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive